{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T04:04:00Z","timestamp":1792728240634,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Neurobiology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.conb.2021.07.001","type":"journal-article","created":{"date-parts":[[2021,9,3]],"date-time":"2021-09-03T06:27:31Z","timestamp":1630650451000},"page":"39-47","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Polyglutamine diseases"],"prefix":"10.1016","volume":"72","author":[{"given":"Emma L.","family":"Bunting","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah J.","family":"Tabrizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.conb.2021.07.001_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/B978-0-444-63233-3.00017-8","article-title":"Huntington disease","volume":"147","author":"Ghosh","year":"2018","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.conb.2021.07.001_bib2","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ebiom.2019.09.020","article-title":"A\u00a0genetic association study of glutamine-encoding DNA sequence structures, somatic CAG expansion, and DNA repair gene variants, with Huntington disease clinical outcomes","volume":"48","author":"Ciosi","year":"2019","journal-title":"EBioMed"},{"key":"10.1016\/j.conb.2021.07.001_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.ajhg.2019.04.007","article-title":"Length of uninterrupted CAG, independent of polyglutamine size, results in increased somatic instability, hastening onset of Huntington disease","volume":"104","author":"Wright","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.conb.2021.07.001_sref4","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.cell.2019.06.036","article-title":"CAG repeat not polyglutamine length determines timing of Huntington's disease onset","volume":"178","author":"Consortium","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.conb.2021.07.001_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1474-4422(17)30161-8","article-title":"Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study","volume":"16","author":"Moss","year":"2017","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.conb.2021.07.001_bib6","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/brain\/awz115","article-title":"MSH3 modifies somatic instability and disease severity in Huntington's and myotonic dystrophy type 1","volume":"142","author":"Flower","year":"2019","journal-title":"Brain"},{"key":"10.1016\/j.conb.2021.07.001_bib7","doi-asserted-by":"crossref","first-page":"3859","DOI":"10.1093\/hmg\/ddx286","article-title":"A\u00a0modifier of Huntington's disease onset at the MLH1 locus","volume":"26","author":"Lee","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib8","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1074\/jbc.REV119.007678","article-title":"On the wrong DNA track: molecular mechanisms of repeat-mediated genome instability","volume":"295","author":"Khristich","year":"2020","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.conb.2021.07.001_bib9","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/hmg\/ddy375","article-title":"FAN1 modifies Huntington's disease progression by stabilizing the expanded HTT CAG repeat","volume":"28","author":"Goold","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ajhg.2020.05.012","article-title":"Genetic and functional analyses point to FAN1 as the source of multiple Huntington disease modifier effects","volume":"107","author":"Kim","year":"2020","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib11","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1093\/hmg\/ddaa196","article-title":"Promotion of somatic CAG repeat expansion by Fan1 knock-out in Huntington's disease knock-in mice is blocked by Mlh1 knock-out","volume":"29","author":"Loupe","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib12","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1038\/s41598-017-01510-z","article-title":"The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington's disease patients","volume":"7","author":"Neueder","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2021.07.001_bib13","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1038\/s41467-018-06281-3","article-title":"Regulatory mechanisms of incomplete huntingtin mRNA splicing","volume":"9","author":"Neueder","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.07.001_sref14","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1038\/s41467-020-16318-1","article-title":"Truncation of mutant huntingtin in knock-in mice demonstrates exon1 huntingtin is a key pathogenic form","volume":"11","author":"Yang","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.07.001_bib15","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-019-0074-3","article-title":"Spinocerebellar ataxia","volume":"5","author":"Klockgether","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.conb.2021.07.001_bib16","first-page":"175","article-title":"What is the pathogenic CAG expansion length in Huntington's disease?","volume":"10","author":"Donaldson","year":"2021","journal-title":"J\u00a0Huntingt Dis"},{"key":"10.1016\/j.conb.2021.07.001_bib17","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1093\/hmg\/ddaa139","article-title":"Patterns of CAG repeat instability in the central nervous system and periphery in Huntington's disease and in spinocerebellar ataxia type 1","volume":"29","author":"Mouro Pinto","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib18","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/ana.24656","article-title":"DNA repair pathways underlie a common genetic mechanism modulating onset in polyglutamine diseases","volume":"79","author":"Bettencourt","year":"2016","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2021.07.001_bib19","first-page":"75","article-title":"DNA mismatch repair and its role in Huntington's disease","volume":"10","author":"Iyer","year":"2021","journal-title":"J\u00a0Huntingt Dis"},{"key":"10.1016\/j.conb.2021.07.001_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neulet.2018.02.005","article-title":"Ion channel dysfunction in cerebellar ataxia","volume":"688","author":"Bushart","year":"2019","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.conb.2021.07.001_bib21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.neuron.2016.02.011","article-title":"Cerebellar transcriptome profiles of ATXN1 transgenic mice reveal SCA1 disease progression and protection pathways","volume":"89","author":"Ingram","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2021.07.001_bib22","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/ng.3808","article-title":"Disruption of the ATXN1-CIC complex causes a spectrum of neurobehavioral phenotypes in mice and humans","volume":"49","author":"Lu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib23","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.neuron.2018.02.013","article-title":"ATXN1-CIC complex is the primary driver of cerebellar pathology in spinocerebellar ataxia type 1 through a gain-of-function mechanism","volume":"97","author":"Rousseaux","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2021.07.001_bib24","doi-asserted-by":"crossref","first-page":"3249","DOI":"10.1093\/hmg\/ddaa212","article-title":"Altered Capicua expression drives regional Purkinje neuron vulnerability through ion channel gene dysregulation in spinocerebellar ataxia type 1","volume":"29","author":"Chopra","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_sref25","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.neuron.2019.11.019","article-title":"Nicotinamide pathway-dependent Sirt1 activation restores calcium homeostasis to achieve neuroprotection in spinocerebellar ataxia type 7","volume":"105","author":"Stoyas","year":"2020","journal-title":"Neuron"},{"key":"10.1016\/j.conb.2021.07.001_bib26","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1093\/hmg\/ddx281","article-title":"Potassium channel dysfunction underlies Purkinje neuron spiking abnormalities in spinocerebellar ataxia type 2","volume":"26","author":"Dell'Orco","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12311-020-01179-7","article-title":"Antisense oligonucleotide therapy targeted against ATXN3 improves\u00a0potassium channel-mediated Purkinje neuron dysfunction in\u00a0spinocerebellar ataxia type 3","volume":"20","author":"Bushart","year":"2021","journal-title":"Cerebellum"},{"key":"10.1016\/j.conb.2021.07.001_bib28","doi-asserted-by":"crossref","first-page":"29489","DOI":"10.1038\/srep29489","article-title":"4-aminopyridine reverses ataxia and cerebellar firing deficiency in a mouse model of spinocerebellar ataxia type 6","volume":"6","author":"Jayabal","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2021.07.001_bib29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/hmg\/ddy050","article-title":"Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia","volume":"27","author":"Chopra","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib30","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/s41467-020-14931-8","article-title":"Cerebellum-enriched protein INPP5A contributes to selective neuropathology in mouse model of spinocerebellar ataxias type 17","volume":"11","author":"Liu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.07.001_bib31","doi-asserted-by":"crossref","first-page":"104564","DOI":"10.1016\/j.nbd.2019.104564","article-title":"5\u2032UTR-mediated regulation of Ataxin-1 expression","volume":"134","author":"Manek","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2021.07.001_sref32","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1101\/gad.339317.120","article-title":"miR760 regulates ATXN1 levels via interaction with its 5 ' untranslated region","volume":"34","author":"Nitschke","year":"2020","journal-title":"Genes Dev"},{"key":"10.1016\/j.conb.2021.07.001_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.nbd.2018.05.002","article-title":"Reduction of protein kinase A-mediated phosphorylation of ATXN1-S776 in Purkinje cells delays onset of Ataxia in a SCA1 mouse model","volume":"116","author":"P\u00e9rez Ortiz","year":"2018","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.conb.2021.07.001_bib34","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1093\/hmg\/ddy200","article-title":"PAK1 regulates ATXN1 levels providing an opportunity to modify its toxicity in spinocerebellar ataxia type 1","volume":"27","author":"Bondar","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.144955","article-title":"Modulation of ATXN1 S776 phosphorylation reveals the importance of allele-specific targeting in SCA1","volume":"6","author":"Nitschke","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.conb.2021.07.001_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41467-018-06041-3","article-title":"Staufen1 links RNA stress granules and autophagy in a model of neurodegeneration","volume":"9","author":"Paul","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.07.001_bib37","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1038\/s41418-020-0553-9","article-title":"Staufen 1 amplifies proapoptotic activation of the unfolded protein response","volume":"27","author":"Gandelman","year":"2020","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.conb.2021.07.001_bib38","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/ana.26069","article-title":"Staufen1 in human neurodegeneration","volume":"89","author":"Paul","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2021.07.001_bib39","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1097\/WCO.0000000000000856","article-title":"Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment","volume":"33","author":"Grunseich","year":"2020","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.conb.2021.07.001_bib40","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1038\/s41467-019-09923-2","article-title":"Side chain to main chain hydrogen bonds stabilize a polyglutamine helix in a transcription factor","volume":"10","author":"Escobedo","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.conb.2021.07.001_bib41","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/jci.insight.136539","article-title":"Linking epigenetic dysregulation, mitochondrial impairment, and metabolic dysfunction in SBMA motor neurons","volume":"5","author":"Pourshafie","year":"2020","journal-title":"Jci Insight"},{"key":"10.1016\/j.conb.2021.07.001_bib42","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.1038\/s41598-019-40118-3","article-title":"Gene expression analysis reveals early dysregulation of disease pathways and links Chmp7 to pathogenesis of spinal and bulbar muscular atrophy","volume":"9","author":"Malik","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.conb.2021.07.001_bib43","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1080\/15548627.2018.1535292","article-title":"Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration","volume":"15","author":"Rusmini","year":"2019","journal-title":"Autophagy"},{"key":"10.1016\/j.conb.2021.07.001_sref44","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1900907","article-title":"Targeting huntingtin expression in patients with Huntington's disease","volume":"380","author":"Tabrizi","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.conb.2021.07.001_bib45","series-title":"Roche provides update on tominersen programme in manifest Huntington's disease","year":"2021"},{"key":"10.1016\/j.conb.2021.07.001_bib46","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.123193","article-title":"Antisense oligonucleotide-mediated ataxin-1 reduction prolongs survival in SCA1 mice and reveals disease-associated transcriptome profiles","volume":"3","author":"Friedrich","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.conb.2021.07.001_bib47","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/hmg\/ddaa072","article-title":"ALS-associated genes in SCA2 mouse spinal cord transcriptomes","volume":"29","author":"Scoles","year":"2020","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.conb.2021.07.001_bib48","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nature22044","article-title":"Antisense oligonucleotide therapy for spinocerebellar ataxia type 2","volume":"544","author":"Scoles","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.conb.2021.07.001_bib49","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/ana.25264","article-title":"Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice","volume":"84","author":"McLoughlin","year":"2018","journal-title":"Ann Neurol"},{"key":"10.1016\/j.conb.2021.07.001_bib50","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.omtn.2017.04.005","article-title":"Evaluation of antisense oligonucleotides targeting ATXN3 in SCA3 mouse models","volume":"7","author":"Moore","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.conb.2021.07.001_bib51","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.omtn.2017.06.019","article-title":"Antisense oligonucleotide-mediated removal of the polyglutamine repeat in spinocerebellar ataxia type 3 mice","volume":"8","author":"Toonen","year":"2017","journal-title":"Mol Ther Nucleic Acids"},{"key":"10.1016\/j.conb.2021.07.001_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aap8677","article-title":"Antisense oligonucleotides targeting mutant Ataxin-7 restore visual function in a mouse model of spinocerebellar ataxia type 7","volume":"10","author":"Niu","year":"2018","journal-title":"Sci Transl Med"}],"container-title":["Current Opinion in Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821000702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959438821000702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T13:01:14Z","timestamp":1760706074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959438821000702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"alternative-id":["S0959438821000702"],"URL":"https:\/\/doi.org\/10.1016\/j.conb.2021.07.001","relation":{},"ISSN":["0959-4388"],"issn-type":[{"value":"0959-4388","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polyglutamine diseases","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conb.2021.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}